Taj Pharma is the
largest generic pharmaceutical company in India. We hold top
positions in different established markets worldwide and are
building a strong presence in many emerging generics markets.
Today, we market more than 500 products to consumers in more than
40 countries and territories across the globe. Our products cover
a vast array of therapeutic categories, and we offer an extensive
range of dosage forms and delivery systems including oral solids,
controlled-release, steriles, injectables, topicals, liquids,
transdermals, semi-solids and high-potency products.
At
Taj Pharma, we are always ready to meet the challenges of the
dynamic global pharmaceutical industry with its numerous and
wide-ranging issues – from complex research, development and
regulatory conditions to rapidly changing consumer demands.
Our Generics portfolio offers over 100 products in the major
therapeutic areas of gastro-intestinal, cardiovascular, pain
management, oncology, anti-infectives, paediatrics and
dermatology. Brands like Omez, Ciprolet, Nise, Enam, Ketorol,
Exifine and Cetrine enjoy leadership positions in several key
markets, including India, Russia & other countries.
Our deep customer relationships, quality medicines and
consistently delivered promise make us a trusted brand across the
world.
We have capitalized on every opportunity to bring our high-quality
products to more people around the world. A synchronized supply
chain that leverages our strong product development capabilities,
state-of-the-art manufacturing and vertical integration with our
own APIs has created a creditable track record of successful
launches.
Our generics offerings deliver quality at cost-effective prices in
the highly regulated markets of the United States, UK and other
Asian countries.
Any Queries / Know more about Generics
Medicines write us
:
Quality
At
Taj Pharma, we are always ready to meet the challenges of the
dynamic global pharmaceutical industry with its numerous and
wide-ranging issues – from complex research, development and
regulatory conditions to rapidly changing consumer demands.
